Analysis of the methylphenidate's efficacy using the abbreviated version Conners' questionnaire in attention deficit hyperactivity disorder;Análise da eficácia do metilfenidato usando a versão abreviada do questionário de Conners em transtorno de déficit de atenção/hiperatividade

Arquivos de Neuro-Psiquiatria

Volumn 62, Issue 1, 2004, Pages 81-85

  De Andrade, Ênio Roberto ^a,b   Scheuer, Claudia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FMUSP ^*  (Brazil)

Author keywords

ADHD; Conners; Methylphenidate

Indexed keywords

METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; EVALUATION; HEALTH SURVEY; HUMAN; PARENT; PATIENT SELECTION; QUESTIONNAIRE; RATING SCALE; TEACHER;

EID: 1842831993     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2004000100014     Document Type: Article

References (35)

1. Biederman J. Attention-Deficit/Hyperactivity Disorder: a life-span perspective. J Clin Psychiatry 1998;59:4-16.
2. Richters JE, Arnold LE, Jensen PS, et al. NIMH collaborative multisite multimodal treatment study of children with ADHD. I. Background and rationale. J Am Acad Child Adolesc Psychiatry 1995;34:987-1000.
3. Kwasman A, Tinsley BJ, Lepper HS. Pediatricians' knowledge and attitudes concerning diagnosis and treatment of attention deficit and hyperactivity disorders. Arch Pediatr Adolesc Med 1995;149:1211-1216.
4. Buncher PC. Attention-deficit/hyperactivity disorder: a diagnosis for the '90s. Nurse Practitioner 1996;21:43-65.
5. Arnold LE, Abikoff HB, Cantwell DP, et al. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry 1997;54:865-870.
6. Multimodal treatment study of children with attention-deficit/hyperactivity disorder cooperative group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-1086.
7. Hoagwood K, Kelleher KJ, Feil M, Comer DM. Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry 2000;39:198-206.
8. National institutes of health: Consensus development conference statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). J Am Acad Child Adolesc Psychiatry 2000;39:194-197.
9. Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin N Am 2000;9:541-555.
10. Stubbe DE. Attention-deficit/hyperactivity disorder: an overview and historical perspective, current controversies, and future directions. Child Adolesc Psychiatr Clin N Am 2000;9:469-479.
11. Barbosa GA, Gouveia VV. O fator hiperatividade do questionário de Conners: validade conceitual e normas diagnósticas. Temas 1993;46:188-202.
12. Rohde LA, Biederman J, Busnello EA, et al. ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions, and impairments. J Am Acad Child Adolesc Psychiatry 1999;38:716-722.
13. Taylor, E. Syndrome of attention deficit and overactivity. In Rutter M, Taylor E, Hersov L (eds.) Child and adolescent psychiatry modern approaches, 3Ed. Osney Mead: Blackwell, 1994:285-307.
14. Faraone S, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 1998;44:951-958.
15. Hudziak JJ, Heath AC, Madden PF, et al. Latent class and factor analysis of DSM-IV ADHD: a twin study of female adolescents. J Am Acad Child Adolesc Psychiatry 1998;37:848-857.
16. Carlson CL, Mann M. Attention-deficit/hyperactivity disorder, predominantly inattentive subtype. Child Adolesc Psychiatr Clin N Am 2000;9:499-510.
17. Gansler DA, Fucetola R, Krengel M, Stetson S, Zemering R, Makary C. Are there cognitive subtypes in adult attention deficit/hyperactivity disorder J Nerv Ment Dis 1998;186:776-781.
18. Silver LB. Attention-deficit/hyperactivity disorder in adult life. Child Adolesc Psychiatr Clin N Am 2000;9:511-523.
19. Castellanos FX. Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin Pediatr 1997;36:381-393.
20. Greenhill LL, Halperin JM, Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psychiatry 1999;38:503-512.
21. Yepes LE. Tratamiento farmacológico del trastorno de déficit de la atención. Rev Colomb Psiquiatria 1998;17:274-286.
22. Peeples EE, Searls DT, Wellingham-Jones P. Attention-deficit hyperactivity disorder: a longitudinal case study of handwriting characteristics. Percept Mot Skills 1995;81:1243-1252.
23. Green WH. Sympathomimetic amines and central nervous system stimulants. In Child and Adolescent Clinical Psychopharmacology. 3Ed. Philadelphia: Lippincontt Williams & Wilkins, 2001:57-88.
24. Wilens TE, Spencer TJ. The stimulants revisites. Child Adolesc Psychiatr Clin N Am 2000;9:573-603.
25. Spencer TJ, Biederman J, Harding M. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatr 1996;35:1460-1469.
26. Spencer TJ, Biederman J, Wilens T. Growth deficits in ADHD children. Pediatric 1998;102:501-506.
27. Spencer TJ, Biederman J, Wilens T. Pharmacotherapy of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000;9:77-97.
28. Funk JB, Chessare JB, Weaver MT, Exley AR. Attention deficit hyperactivity disorder, creativity, and the effects of methylphenidate. Pediatrics 1993;91:816-819.
29. Matochik JA, Liebenauer LL, King AC, Szymanski HV, Cohen RM, Zametkin AJ. Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment. Am J Psychiatry 1994;151:658-664.
30. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4Ed. Washington DC, 1994.
31. Wechsler D. Wechsler intelligence scale for children; revised. New York: Psychological Corporation, 1981.
32. Maxwell DL, Satake E. Research and statistical methods in communication disorders. Baltimore: Williams & Wilkins, 1997.
33. Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H, Kuiper M. Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatr 1995; 34:1025-1032.
34. Carmo WB Filho. Uso do metilfenidato no transtorno do déficit de atenção. Infanto-Rev Neuropsiq Inf Adol 1998;6:62-64.
35. Denney CB, Rapport MD. Predicting methylphenidate response in children with ADHD: theoretical, empirical, and conceptual models. J Am Acad Child Adolesc Psychiatr 1999;38:393-401.